IATF approves COVID-19 clinical trials on pediatric age group

Clinical trials focused on fighting emerging variants of the COVID-19 virus might start soon, MalacaƱang announced on Saturday (Sept. 4).

The Inter-Agency Task Force (IATF), subject to the considerations of the Food and Drug Administration (FDA), approved the recommendation for sponsors or trialists.

The IATF plans to shift its focus towards people of different age groups and people with comorbidities, or the immunocompromised, to be more inclusive in addressing the COVID-19 pandemic, Presidential Spokesperson Harry Roque said in a statement.

The recommendation to prioritize Phase three clinical trials that will focus on the pediatric age group of six months to 12 years old was approved by the IATF last Sept.4.

The Phase three clinical trials will also include the elderly (more than 60 years old), pregnant mothers, patients with immunodeficiency, patients with autoimmune diseases, patients with renal diseases, and patients with chronic respiratory diseases. – PG – bny

Popular

PH passes 2027 ASEAN chairship to Singapore

By Dean Aubrey Caratiquet As the 49th ASEAN Summit drew to a close, President Ferdinand R. Marcos Jr. looked back at the priorities that the...

Trade, tourism take center stage at ASEAN-India Summit

By Dean Aubrey Caratiquet Moving beyond regional boundaries, ASEAN continues to build upon its relationship with India, which can create further opportunities for both parties. Spearheading...

ASEAN-Japan Summit focuses on energy, defense, cybersecurity, people-to-people exchanges

By Dean Aubrey Caratiquet Beyond building energy resiliency, the Philippines also expressed its interest to work with other member states in the areas of cybersecurity,...

Security, tech, trade among key highlights in ASEAN-ROK Summit

By Dean Aubrey Caratiquet Beyond culture and cuisine, South Korea’s contributions to the region continue to expand under the country’s partnership with the Association of...